| 发明名称 |
USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 摘要 |
The present invention relates to use of FVII and/or FVIIa and/or another TF agonist and/or FVIIai and/or another TF antagonist in therapeutic treatment of pathological conditions that can be related to cell migration or treated by specific regulation of cell migration or chemotaxis. The invention also relates to the use of FVII and/or FVIIa and/or another TF agonist and/or FVIIai and/or another TF antagonist in therapeutic treatment of pathological conditions that can be related to regulation of expression of at least one gene in a cell, e.g., <i>Cyr61</i>gene.
|
| 申请公布号 |
WO0105353(A3) |
申请公布日期 |
2001.07.19 |
| 申请号 |
WO2000DK00401 |
申请日期 |
2000.07.14 |
| 申请人 |
NOVO NORDISK A/S;EZBAN, MIRELLA;PETERSEN, LARS, CHRISTIAN;SIEGBAHN, AGNETA |
发明人 |
EZBAN, MIRELLA;PETERSEN, LARS, CHRISTIAN;SIEGBAHN, AGNETA |
| 分类号 |
C12N15/09;A61K;A61K38/00;A61K38/36;A61K38/43;A61K38/46;A61P9/00;A61P35/00;A61P35/04;A61P43/00;C07K14/47;C12N5/06;C12N9/64;(IPC1-7):A61K38/36 |
主分类号 |
C12N15/09 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
